Department of Pathology and Cardiovascular MRC, Dongguk University, Kyungju 780-714, South Korea.
Environ Toxicol Pharmacol. 2007 Nov;24(3):218-22. doi: 10.1016/j.etap.2007.05.008. Epub 2007 May 29.
Medicinal extracts of Cho-Deung-san and Uncaria sinensis Havil. (UR) have previously been shown to have inhibitory effects on migration of vascular smooth muscle cells (VSMC) and matrix metalloproteinase (MMP)-2/9 production, which play key roles in the development of atherosclerosis. In this study, we have more extensively investigated the inhibitory effect of UR on MMP-9 activity and TNF-α induced human aortic smooth muscle cells (HASMC) migration. The result from gelatin zymography showed that UR inhibited MMP-9 activity in a dose-dependent manner (IC(50)=55μg/ml). In addition, UR strongly inhibited the migration of HASMC induced by TNF-α treatment (IC(50)=125μg/ml), although it has very low cytotoxic effect on HASMC (IC(50)>500μg/ml). These results suggest that UR is a potential anti-atherosclerotic agent through inhibition of MMP-9 activity and VSMC migration.
此前已证实草豆蔻和钩藤(UR)的药用提取物对血管平滑肌细胞(VSMC)迁移和基质金属蛋白酶(MMP)-2/9 产生具有抑制作用,而这两者在动脉粥样硬化的发生发展中起着关键作用。在这项研究中,我们更广泛地研究了 UR 对 MMP-9 活性和 TNF-α诱导的人主动脉平滑肌细胞(HASMC)迁移的抑制作用。明胶酶谱结果表明,UR 呈剂量依赖性地抑制 MMP-9 活性(IC50=55μg/ml)。此外,UR 强烈抑制 TNF-α处理诱导的 HASMC 迁移(IC50=125μg/ml),尽管它对 HASMC 具有非常低的细胞毒性作用(IC50>500μg/ml)。这些结果表明,UR 通过抑制 MMP-9 活性和 VSMC 迁移可能是一种潜在的抗动脉粥样硬化药物。